0001140361-23-031194.txt : 20230623 0001140361-23-031194.hdr.sgml : 20230623 20230623163106 ACCESSION NUMBER: 0001140361-23-031194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230622 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KABAKOFF DAVID S CENTRAL INDEX KEY: 0001024008 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38905 FILM NUMBER: 231038185 MAIL ADDRESS: STREET 1: C/O SPIROS DEVELOPMENT CORP II INC STREET 2: 7475 LUSK BLVD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NextCure, Inc. CENTRAL INDEX KEY: 0001661059 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475231247 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 BUSINESS PHONE: 240-399-4900 MAIL ADDRESS: STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200 CITY: BELTSVILLE STATE: MD ZIP: 20705 4 1 form4.xml X0407 4 2023-06-22 0001661059 NextCure, Inc. NXTC 0001024008 KABAKOFF DAVID S C/O NEXTCURE, INC. 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 true false Stock Option (Right to Buy) 1.62 2023-06-22 4 A 0 14250 0 A 2033-06-21 Common Stock 14250 14250 D The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders. /s/ Steven P. Cobourn, as attorney-in fact for David S. Kabakoff 2023-06-23